Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Tot Biopharm Raises Us$102 Million In Series B Financing Round
Venture Capital

Tot Biopharm Raises Us$102 Million In Series B Financing Round

by vcaonline.com posted 4months ago 22 views
TOT BIOPHARM raises US$102 million in Series B Financing RoundTOT BIOPHARM's high-end oncology drug technology platform garners great attention SUZHOU, China, August 8, 2018-- TOT BIOPHARM Company Limited ("TOT BIOPHARM"), headquartered in Suzhou Industrial Park, China, today announced the completion of a Series B financing round, raising US$102 million in capital. The financing round was supported by China Universal (Cayman) GP Limited and several renowned domestic and foreign investors, as well as investors who had participated in earlier rounds, including Center Laboratories Group, Vivo Capital, Chengwei Capital, Yuanta Financial Holdings Group and Cathay Capital.

In this article